Molecular subtypes and lymph-node metastasis in endometrial cancer: An updated systematic review and meta-analysis
- 2 June 2026
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 67, 102463
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysisClinical and Translational Oncology, 2024
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?Gynecologic Oncology, 2022
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastasesGynecologic Oncology, 2022
- Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatmentGynecologic Oncology, 2022
- Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-DGynecologic Oncology, 2020
- TCGA molecular groups of endometrial cancer: Pooled data about prognosisGynecologic Oncology, 2019
- Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancerCancer, 2017
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983